Biota provides a PFAS RapidTest kit that delivers quantitative field results in about 15 minutes, along with the MagnaPrep system that streamlines laboratory confirmatory analysis. The integrated platform consolidates real‑time field data with lab results, enabling remediation firms to verify treatment efficacy quickly and labs to increase throughput.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
PFAS testing for remediation projects typically requires sending samples to a laboratory, resulting in turnaround times of two to three weeks. The delay hampers decision‑making for treatment firms and limits the ability of testing labs to process more cases efficiently.
Solution
Biota delivers a workflow that captures PFAS concentrations in the field within approximately 15 minutes using its PFAS RapidTest kit, while also providing tools that accelerate confirmatory laboratory analysis. The platform combines rapid, portable testing with sample preparation equipment (MagnaPrep) to generate reliable ppb‑to‑ppt level data in real time. Results are instantly available to treatment companies, enabling them to demonstrate efficacy to clients and close contracts faster. At the same time, laboratories receive pre‑processed samples that reduce confirmatory testing time, allowing them to increase throughput, revenue, and profit margins. By linking field data to lab confirmation, Biota creates a seamless end‑to‑end PFAS analysis solution.
Target Audience
Primary customers are environmental remediation firms that need on‑site PFAS verification and analytical laboratories that perform regulated PFAS confirmatory testing.
Features
- PFAS RapidTest field kit delivering quantitative results in ~15 minutes with ppb‑to‑ppt sensitivity
- MagnaPrep sample preparation system that streamlines laboratory confirmatory workflows
- Integrated data platform that consolidates field and lab results for rapid decision‑making
- Compatibility with monitoring programs, treatment system development, and high‑volume lab operations
- Real‑time reporting that reduces traditional 2‑3 week result cycles to minutes